Ignite Creation Date:
2024-05-05 @ 5:22 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00441103
Status:
COMPLETED
Last Update Posted:
2014-07-09
First Post:
2007-02-26
Brief Title:
A Study to Evaluate Rebif New Formulation Interferon-beta-1a in Relapsing Remitting Multiple Sclerosis
Sponsor:
Merck KGaA Darmstadt Germany
Organization:
Merck KGaA Darmstadt Germany
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-12
Start Date Type:
None
Primary Completion Date:
2008-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-02
Completion Date Type:
ACTUAL
First Submit Date:
2007-02-26
First Submit QC Date:
February 26 2007
Study First Post Date:
2007-02-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2010-07-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-06-06
Last Update Post Date:
2014-07-09
Last Update Post Date Type:
ESTIMATED